Stratasys FY2025 EPS Forecast Reduced by Cantor Fitzgerald

Stratasys Ltd. (NASDAQ:SSYS) – Stock analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for Stratasys in a research note issued to investors on Thursday, March 6th. Cantor Fitzgerald analyst T. Jensen now anticipates that the technology company will post earnings of ($0.11) per share for the year, down from their prior estimate of ($0.04). Cantor Fitzgerald has a “Overweight” rating and a $15.00 price target on the stock. The consensus estimate for Stratasys’ current full-year earnings is ($0.40) per share.

Several other analysts also recently issued reports on SSYS. StockNews.com downgraded shares of Stratasys from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Needham & Company LLC upped their price target on shares of Stratasys from $12.00 to $13.00 and gave the company a “buy” rating in a report on Thursday, March 6th. Finally, Craig Hallum upped their price target on shares of Stratasys from $12.00 to $15.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, Stratasys presently has a consensus rating of “Moderate Buy” and a consensus price target of $12.20.

Stratasys Price Performance

Shares of NASDAQ SSYS opened at $9.51 on Monday. Stratasys has a 12-month low of $6.05 and a 12-month high of $12.88. The company has a market capitalization of $678.80 million, a PE ratio of -7.20 and a beta of 1.28. The firm’s 50-day moving average is $10.26 and its two-hundred day moving average is $8.95.

Stratasys (NASDAQ:SSYS) last released its quarterly earnings data on Wednesday, March 5th. The technology company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.01. Stratasys had a negative net margin of 16.13% and a negative return on equity of 3.75%. The firm had revenue of $150.40 million for the quarter, compared to the consensus estimate of $151.01 million. During the same quarter in the previous year, the firm earned $0.02 earnings per share. The firm’s revenue was down 3.8% on a year-over-year basis.

Hedge Funds Weigh In On Stratasys

A number of institutional investors have recently modified their holdings of the company. Formidable Asset Management LLC raised its position in shares of Stratasys by 4.1% in the fourth quarter. Formidable Asset Management LLC now owns 24,545 shares of the technology company’s stock valued at $218,000 after buying an additional 965 shares during the last quarter. Squarepoint Ops LLC raised its position in shares of Stratasys by 782.2% in the fourth quarter. Squarepoint Ops LLC now owns 103,209 shares of the technology company’s stock valued at $918,000 after buying an additional 91,510 shares during the last quarter. Two Sigma Investments LP acquired a new position in shares of Stratasys in the fourth quarter valued at approximately $261,000. Point72 Asset Management L.P. raised its position in shares of Stratasys by 12.1% in the fourth quarter. Point72 Asset Management L.P. now owns 28,371 shares of the technology company’s stock valued at $252,000 after buying an additional 3,071 shares during the last quarter. Finally, Millennium Management LLC raised its position in shares of Stratasys by 8.4% in the fourth quarter. Millennium Management LLC now owns 90,715 shares of the technology company’s stock valued at $806,000 after buying an additional 7,066 shares during the last quarter. Institutional investors and hedge funds own 75.77% of the company’s stock.

About Stratasys

Stratasys Ltd. provides connected polymer-based 3D printing solutions. It offers range of 3D printing systems, which includes polyjet printer, Fused Deposition Modeling (FDM) printers, stereolithography printing systems, origin P3 printers, and selective absorption fusion printer for additive manufacturing, and tooling and rapid prototyping for various vertical markets, such as automotive, aerospace, consumer products and healthcare.